Keyence Corp
TSE:6861
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
53 120
76 750
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Keyence Corp
Current Assets | 1.6T |
Cash & Short-Term Investments | 1.2T |
Receivables | 294.7B |
Other Current Assets | 90.1B |
Non-Current Assets | 1.5T |
Long-Term Investments | 1.4T |
PP&E | 77.7B |
Intangibles | 5.8B |
Other Non-Current Assets | 39.7B |
Current Liabilities | 153.5B |
Accounts Payable | 18.4B |
Accrued Liabilities | 17.1B |
Other Current Liabilities | 118B |
Non-Current Liabilities | 12.4B |
Other Non-Current Liabilities | 12.4B |
Balance Sheet
Keyence Corp
Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Cash & Cash Equivalents |
416 956
|
437 675
|
468 206
|
476 637
|
401 201
|
464 296
|
433 656
|
520 356
|
|
Cash Equivalents |
416 956
|
437 675
|
468 206
|
476 637
|
401 201
|
464 296
|
433 656
|
520 356
|
|
Short-Term Investments |
260 247
|
370 055
|
394 999
|
467 502
|
528 797
|
540 276
|
506 802
|
612 420
|
|
Total Receivables |
127 613
|
159 910
|
168 995
|
162 211
|
186 477
|
247 363
|
296 630
|
306 143
|
|
Accounts Receivables |
127 613
|
159 910
|
168 995
|
162 211
|
186 477
|
247 363
|
296 630
|
245 649
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60 494
|
|
Inventory |
24 343
|
34 847
|
38 349
|
33 677
|
34 940
|
62 072
|
87 389
|
77 613
|
|
Other Current Assets |
12 871
|
20 939
|
7 834
|
8 889
|
6 808
|
8 562
|
11 621
|
15 295
|
|
Total Current Assets |
842 030
|
1 023 426
|
1 078 383
|
1 148 916
|
1 158 223
|
1 322 569
|
1 336 098
|
1 531 827
|
|
PP&E Net |
18 341
|
21 426
|
24 443
|
25 554
|
23 806
|
26 382
|
67 305
|
75 870
|
|
PP&E Gross |
18 341
|
21 426
|
24 443
|
25 554
|
23 806
|
26 382
|
67 305
|
75 870
|
|
Accumulated Depreciation |
37 977
|
40 666
|
44 541
|
48 896
|
54 129
|
62 530
|
71 130
|
84 803
|
|
Intangible Assets |
3 259
|
5 204
|
5 888
|
5 172
|
4 251
|
3 516
|
3 692
|
4 792
|
|
Long-Term Investments |
384 182
|
432 981
|
557 368
|
647 422
|
813 077
|
939 748
|
1 206 730
|
1 314 220
|
|
Other Long-Term Assets |
2 779
|
3 185
|
9 831
|
8 954
|
10 517
|
31 822
|
36 604
|
38 083
|
|
Total Assets |
1 250 591
N/A
|
1 486 222
+19%
|
1 675 913
+13%
|
1 836 018
+10%
|
2 009 874
+9%
|
2 324 037
+16%
|
2 650 429
+14%
|
2 964 792
+12%
|
|
Liabilities | |||||||||
Accounts Payable |
7 322
|
10 645
|
6 309
|
9 619
|
10 540
|
15 911
|
18 381
|
13 725
|
|
Accrued Liabilities |
8 382
|
10 131
|
10 165
|
10 087
|
11 297
|
14 360
|
15 697
|
16 841
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
44 375
|
76 782
|
69 152
|
55 673
|
72 684
|
116 281
|
115 183
|
114 796
|
|
Total Current Liabilities |
60 079
|
97 558
|
85 626
|
75 379
|
94 521
|
146 552
|
149 261
|
145 362
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
5 960
|
7 607
|
1 978
|
2 556
|
2 509
|
3 902
|
9 534
|
13 237
|
|
Total Liabilities |
66 039
N/A
|
105 165
+59%
|
87 604
-17%
|
77 935
-11%
|
97 030
+25%
|
150 454
+55%
|
158 795
+6%
|
158 599
0%
|
|
Equity | |||||||||
Common Stock |
30 637
|
30 637
|
30 637
|
30 637
|
30 637
|
30 637
|
30 637
|
30 637
|
|
Retained Earnings |
1 120 874
|
1 316 311
|
1 524 268
|
1 698 140
|
1 846 924
|
2 101 779
|
2 403 814
|
2 700 699
|
|
Additional Paid In Capital |
30 533
|
30 537
|
30 537
|
30 538
|
30 541
|
30 541
|
30 541
|
30 541
|
|
Unrealized Security Profit/Loss |
2 679
|
3 648
|
2 924
|
2 015
|
5 418
|
3 428
|
2 278
|
261
|
|
Treasury Stock |
3 608
|
3 658
|
3 689
|
3 734
|
3 763
|
3 785
|
3 796
|
3 819
|
|
Other Equity |
3 437
|
3 582
|
3 632
|
487
|
3 087
|
10 983
|
28 160
|
47 874
|
|
Total Equity |
1 184 552
N/A
|
1 381 057
+17%
|
1 588 309
+15%
|
1 758 083
+11%
|
1 912 844
+9%
|
2 173 583
+14%
|
2 491 634
+15%
|
2 806 193
+13%
|
|
Total Liabilities & Equity |
1 250 591
N/A
|
1 486 222
+19%
|
1 675 913
+13%
|
1 836 018
+10%
|
2 009 874
+9%
|
2 324 037
+16%
|
2 650 429
+14%
|
2 964 792
+12%
|
|
Shares Outstanding | |||||||||
Common Shares Outstanding |
243
|
243
|
243
|
243
|
243
|
243
|
243
|
243
|